Jyong Biotech Quick Ratio 1971-1970 | MENS

Historical quick ratio values for Jyong Biotech (MENS) over the last 10 years.
Jyong Biotech Quick Ratio Historical Data
Date Current Assets - Inventory Current Liabilities Quick Ratio
Sector Industry Market Cap Revenue
Medical MED-BIOMED/GENE $0.722B $0.000B
Jyong Biotech Ltd. is a science-driven biotechnology company. It involved in developing and commercializing new drugs mainly specializing in the treatment of urinary system diseases, with an initial focus on the markets of the U.S., the EU and Asia. Jyong Biotech Ltd. is based in New Taipei City, Taiwan.
Stock Name Country Market Cap PE Ratio
Caris Life Sciences,�Inc (CAI) $6.821B 0.00
Slide Insurance Holdings (SLDE) United States $2.580B 0.00
Flowco Holdings (FLOC) United States $1.616B 0.00
New Providence Acquisition III (NPAC) $0.394B 0.00
Inflection Point Acquisition III (IPCX) $0.351B 0.00
Aduro Clean Technologies (ADUR) Canada $0.273B 0.00
Oaktree Acquisition III Life Sciences (OACC) United States $0.235B 0.00
Range Capital Acquisition (RANG) United States $0.143B 0.00
Tavia Acquisition (TAVI) $0.142B 0.00
YSX Tech (YSXT) China $0.121B 0.00
Youxin Technology (YAAS) China $0.111B 0.00
CO2 Energy Transition (NOEM) United States $0.096B 0.00
Leishen Energy Holding (LSE) China $0.090B 0.00
ChampionsGate Acquisition (CHPG) $0.087B 0.00
YHN Acquisition I (YHNA) $0.082B 0.00
Uni-Fuels Holdings (UFG) $0.069B 0.00
Happy City Holdings (HCHL) $0.036B 0.00
PicoCELA (PCLA) Japan $0.033B 0.00
New Century Logistics (BVI) (NCEW) Hong Kong, SAR China $0.021B 0.00
Hong Kong Pharma Digital Technology Holdings (HKPD) $0.016B 0.00
Sky Quarry (SKYQ) United States $0.014B 0.00